title: Inhibition of P2X4 function by P2Y6 UDP receptors in microglia.
abstract: ATP-gated P2X4 receptor channels expressed in spinal microglia actively participate in central sensitization, making their functional regulation a key process in chronic pain pathologies. P2Y6 metabotropic Gq -coupled receptors, also expressed in microglia, are involved in the initial response to nerve injury, triggering phagocytosis upon activation by UDP. It has been reported recently that expression of both P2X4 and P2Y6 is upregulated in activated microglia following nerve injury. We show here, in resting as well as LPS-activated primary microglia, that P2Y6 decreases P2X4-mediated calcium entry and inhibits the dilation of P2X4 channels into a large-conductance pore measured with a YO-PRO-1 uptake assay. Furthermore, P2Y6 activation modulates the ATP-dependent migration of microglia, a process likely involved in their shift from migratory to phagocytic phenotype. Reconstituting the P2X4-P2Y6 interaction in recombinant systems shows that P2Y6 activation decreases P2X4 current amplitude, activation and desensitization rates, and reduces P2X4 channel permeability to the large cation NMDG(+) . Phospholipase C-mediated hydrolysis of the phosphoinositide PI(4,5)P2 , a necessary cofactor for P2X4 channel function, underlies this inhibitory crosstalk. As extracellular levels of both ATP and UDP are increased in the spinal cord following nerve injury, the control of P2X4 activity by P2Y6 might play a critical role in regulating neuropathic pain-inducing microglial responses.
authors.affiliation: Department of Neurology and Neurosurgery, Montreal Neurological Institute, Alan Edwards Center for Research on Pain, McGill University, Montréal, Québec, H3A 2B4, Canada.
authors.forename: Louis-Philippe
authors.initials: LP
authors.lastname: Bernier
authors.forename: Ariel R
authors.initials: AR
authors.lastname: Ase
authors.forename: Éric
authors.initials: É
authors.lastname: Boué-Grabot
authors.forename: Philippe
authors.initials: P
authors.lastname: Séguéla
mesh_terms: D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D017628:Microglia / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D018048:Receptors, Purinergic P2 / Q000235:genetics / Q000378:metabolism*; D058848:Receptors, Purinergic P2X4 / Q000235:genetics / Q000378:metabolism*; D015854:Up-Regulation; D014530:Uridine Diphosphate / Q000378:metabolism
chemical_list: D008070:Lipopolysaccharides; D018048:Receptors, Purinergic P2; D058848:Receptors, Purinergic P2X4; C099845:purinoceptor P2Y6; D014530:Uridine Diphosphate; D000255:Adenosine Triphosphate; D002118:Calcium
keywords: calcium; pain; purinoceptor